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Kounis syndrome (KS) was first described in 1991 by 
Kounis and Zavras [1]. The syndrome is characterized by the 
simultaneous presence of anaphylactic and cardiac events [1]. 
KS is also known as allergic angina or allergic myocardial 
infarction. It is thought that following an allergic stimulus, 
inflammatory mediators are released by mast cells, leading 
to spastic contraction of coronary smooth muscle cells [2,3]. 
Three types of KS have been described [4], as follows: 
type I, coronary vasospasm without significant coronary 
disease; type II, patients with pre-existing coronary disease in 
which the release of pro-inflammatory mediators (histamine, 
leukotrienes and serotonin) can cause vasospasm or instability 
of atherosclerotic plaques; and type III, in which drug-
eluting stent thrombosis is associated with a hypersensitivity 
reaction [5]. Although several drugs (antibiotics, nonsteroidal 
anti-inflammatory drugs, anticoagulants, corticosteroids, 
anesthetics, and contrast media) have been associated with KS, 
antibiotics are the most frequently involved [6,7]. Recently, 
Renda et al [8] identified the largest case series on KS 
associated with antibiotics, with 37.5% of all cases involving 
amoxicillin/clavulanic acid (6 cases) and the remaining 
10 cases caused by amoxicillin alone, piperacillin/tazobactam, 
ceftriaxone, cefazolin, levofloxacin, and metronidazole. 
We report the case of a 56-year-old man who developed 
KS immediately after intravenous administration of cefazolin. 
To the best of our knowledge, this is the first case of KS with 
selective anaphylaxis to cefazolin. Sánchez et al [9] reported 
type I KS due to rocuronium and/or cefazolin with positive 
skin test results to both drugs, although, given that the authors 
did not present any further data (skin test with the remaining 
ß-lactams or drug provocation tests), we cannot consider this 
case to be clearly selective or even caused only by cefazolin. 
The patient had a medical history of dyslipidemia and no 
personal history of allergy, although he did have a family history 
of drug allergy (brother with a history of penicillin allergy). 
He underwent knee arthroscopy (for meniscus tear), with no 
complications during the procedure. He was always kept under 
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close observation in the operating room through pulse oximetry, 
noninvasive blood pressure, and ECG. In the postoperative 
period, 8 hours after surgery and less than 5 minutes after 
intravenous administration of cefazolin, the patient experienced 
severe hypotension (blood pressure, 60-40 mmHg) and 
desaturation (peripheral oxygen saturation, 62%) associated 
with a pattern of right cardiac overload (S1Q3T3) with diffuse 
ST depression on ECG and a peak troponin I level of 7 ng/mL 
(normal <0.06 ng/mL). Transthoracic echocardiography 
revealed segmental alterations and compromised left ventricle 
systolic function that led to a coronary angiography, which 
revealed severe right coronary spasm, with no further 
disease. The patient was treated in the intensive care unit with 
epinephrine, clemastine, hydrocortisone, and ranitidine. After 
coronary angiography, norepinephrine and isosorbide dinitrate 
were administered by perfusion, with a good response. After 
7 days, the patient was discharged with no symptoms and 
normal ECG and transthoracic echocardiography findings. 
After discharge, the patient was sent to the immunoallergy 
department for further study. 
The allergology work-up was performed according to the 
recommendations of the European Network of Drug Allergy/
European Academy of Allergy and Clinical Immunology [10]. 
Serum-specific IgE antibodies and skin testing were performed 
at a 4-week interval after the clinical reaction; skin testing was 
a crucial step for assessing cross-reactivity within the β-lactam 
antibiotics, including cephalosporins. β-Lactam skin testing 
was performed with solutions of benzylpenicilloyl octa-L-
lysine (PPL), sodium benzylpenilloate (minor determinant 
[MD]), and amoxicillin (DAP, Diater), as well as penicillin 
G, cefazolin, cefuroxime, and ceftriaxone [10]. Specific 
IgE testing (ImmunoCAP, Thermo Fisher) for penicillin G, 
penicillin V, amoxicillin, ampicillin, and cefaclor was 
negative (<0.10 kU/L). Skin testing was performed after 
written informed consent was provided. Skin prick test 
results were negative to all β-lactam antibiotics, as well as 
to latex. Intradermal testing with cefazolin was positive at a 
concentration of 2.5 mg/mL (wheal, 13 mm), with erythema 
and pruritus in the immediate reading (20 minutes). All 
intradermal tests with the other β-lactam antibiotics were 
negative: PPL 5×10–5 mM, MD 2×10–5 mM, penicillin G 10 000 
IU/mL, amoxicillin 20 mg/mL, cefuroxime 2.5 mg/mL, and 
ceftriaxone 2.5 mg/mL. There were no late reactions. Since the 
anaphylactic reaction occurred during the postoperative period, 
the anesthetic drugs administered during surgery (midazolam, 
fentanyl, rocuronium, and propofol) 8 hours before the reaction 
were ruled out. 
At a subsequent appointment, the patient was successfully 
challenged with amoxicillin (total cumulative dose of 1010 mg). 
The patient subsequently tolerated cefuroxime. 
We conclude that the patient fulfilled the criteria for the 
diagnosis of KS (type I), with a severe and selective IgE-mediated 
allergy to cefazolin. Allergy to penicillin derivatives and to 
second- and third-generation cephalosporins was excluded.
Although considered a rare syndrome, KS is increasingly 
reported, possibly reflecting increased awareness of this 
syndrome. A large percentage of the reported cases occurred 
with antibiotics, more precisely with amoxicillin/clavulanic 
acid, and very few cases have been shown to be related to 
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other antibiotics. To our knowledge, this is the first case of KS 
with confirmed selective IgE-mediated allergy to cefazolin.
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